This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Ventilation-perfusion scanning

Authoring team

Ventilation-perfusion scanning is a radiological procedure which is often used to confirm or exclude the diagnosis of pulmonary embolism. It may also be used to monitor treatment.

The ventilation part of the scan is the inhalation of Krypton 81m, which has a short half life and is a pure gamma emitter. Ventilation is assessed under a gamma camera.

The perfusion part of the scan is achieved by injecting the patient with technetium 99m, which is coupled with macro aggregated albumin (MAA). This molecule has a diameter of 30 to 50 micrometres, and thus sticks in the pulmonary capillaries. Sufficiently few molecules are injected for this not to have a physiological effect. An embolus shows up as a cold area when the patient is placed under a gamma camera. The MAA has a half life of about 10 hours, the technecium about 6 hours; there are no contraindications for this investigation, however in a patient with a right to left shunt the investigation will become a whole body scan, and thus is not useful.


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.